Poor labeling of respiratory therapy medications can impact patient safety

Poor labeling of respiratory therapy medications can impact patient safety

Collection:
Health Policy and Services Research
Contributor(s):
Pennsylvania. Patient Safety Authority, issuing body.
ECRI (Organization), issuing body.
Institute for Safe Medication Practices, issuing body.
Publication:
[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, [2005]
Language(s):
English
Format:
Text
Subject(s):
Bronchodilator Agents -- therapeutic use
Drug Labeling
Drug Packaging
Medication Errors -- prevention & control
Respiratory System Agents -- therapeutic use
Pennsylvania
United States
Genre(s):
Technical Report
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY-NC-DC license. (More information)
Extent:
1 online resource (1 PDF file (3 pages))
Illustrations:
Illustrations
NLM Unique ID:
101727283 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101727283